Status:
COMPLETED
Effects of Corticotropin Releasing Hormone (CRH) on the Sleep in Patients With Hypopituitarism
Lead Sponsor:
Max-Planck-Institute of Psychiatry
Conditions:
Hypopituitarism
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
In contrast to healthy subjects, patients with hypopituitarism do not exhibit endocrine responses when hormones are injected. This is at least true for those with a complete insufficiency of the anter...
Eligibility Criteria
Inclusion
- Patients with hypopituitarism
- Age 18-75 years
- Complete insufficiency of the anterior pituitary
- Stable hormone substitution for at least 3 months
Exclusion
- Hormone excess in the past
- Sleep disorder, e.g. sleep apnea syndrome
- Healthy controls
- Inclusion Criteria:
- Age 18-75 years
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00666068
Start Date
February 1 2008
End Date
December 1 2008
Last Update
May 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Max Planck Institute of Psychiatry
Munich, Germany, 80804